Commonwealth Equity Services
OCUL icon

Commonwealth Equity Services’s Ocular Therapeutix OCUL Stock Holding History

Commonwealth Equity Services’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$88.5K Sell
10,447
-141
-1% -$1.34K ﹤0.01% 4150
2025
Q4 		$129K Buy
10,588
+231
+2% +$2.81K ﹤0.01% 4074
2025
Q3 		$121K Sell
10,357
-4,003
-28% -$47.9K ﹤0.01% 4055
2025
Q2 		$133K Buy
+14,360
New +$112K ﹤0.01% 4012

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Commonwealth Equity Services's OCUL Position: Q1 2026 in Review

Commonwealth Equity Services reduced its Ocular Therapeutix (OCUL) stake by 1.3% in Q1 2026, selling an estimated $1.34K and leaving 10,447 shares worth $88.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4150.

Commonwealth Equity Services first reported a position in OCUL in Q2 2025 and has held it in 4 quarters since. The position peaked at $133K in Q2 2025. 269 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.

  • Commonwealth Equity Services held 10,447 shares of Ocular Therapeutix worth $88.5K as of Q1 2026.
  • Commonwealth Equity Services sold 141 Ocular Therapeutix shares in Q1 2026, an estimated $1.34K.
  • Ocular Therapeutix made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q1 2026, its #4150 holding.
  • Commonwealth Equity Services first reported a position in Ocular Therapeutix in Q2 2025 and has held it in 4 quarters since.
  • Commonwealth Equity Services's Ocular Therapeutix position peaked at $133K in Q2 2025.
  • 269 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.

Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.